Download NPPA notification No. S.O. S.O. 87(E) dt 06-01-2023, the link is given below: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 4 scheduled formulations vide vide S.O. 87(E) dt 06-01-2023 based on the decision of 106th Authority meeting dated 30.12.2022

Download notification No. S.O. 87(E) dt 06-01-2023

This price fixation followed the decision of the 106th Authority meeting on December 30, 2022.

In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India the Ministry of Chemicals and Fertilizers and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No SO1499(E) dated 30th March, 2022 in so far as it relates to formulation packs mentioned in the table below, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table herein below as ceiling price exclusive of goodsand services tax applicable, if any, in respect of the Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

Table

Sl. No.Name of the Scheduled Formulation  Dosage form and strength  UnitCeiling Price (Rs.)(1)(2)(3)(4)(5)1SulfasalazineTablet 500 mg1 Tablet4.212DigoxinTablet 0.25mg1 Tablet1.193EthambutolTablet 600mg1 Tablet3.644PhenytoinTablet 300mg1 Tablet4.89  5Atazanavir (A) +Ritonavir(B)Tablet 300mg(A) + Tablet 100mg(B)  1 Tablet  89.036CeftriaxonePowder for Injection 500 mg1 Vial44.847CeftriaxonePowder for Injection 250 mg1 Vial25.288CeftriaxonePowder for Injection 1000mg1 Vial55.649CeftriaxonePowder for Injection 2000mg1 Vial123.1810CefotaximePowder for Injection 250 mg1 Vial15.8011CefotaximePowder for Injection 500 mg1 Vial21.7412CefotaximePowder for Injection 1000mg1 Vial35.64  13Piperacillin (A) +Tazobactam(B)Powder for Injection 1000mg(A)+125mg(B)  1 Vial  88.88  14Piperacillin (A) +Tazobactam(B)Powder for Injection 2000mg(A)+250mg(B)  1 Vial  170.83  15Piperacillin (A) +Tazobactam(B)Powder for Injection 4000mg(A)+500mg(B)  1 Vial  356.2116AmpicillinPowder for Injection 500 mg1 Vial12.7117MetoprololTablet 25mg1 Tablet3.7518MetoprololTablet 50mg1 Tablet5.21

19PropranololTablet 40mg1 Tablet2.8720FluconazoleTablet 200mg1 Tablet15.5721EthambutolTablet 800mg1 Tablet4.4222PyrazinamideTablet 1000mg1 Tablet9.3923PyrazinamideTablet 500mg1 Tablet4.3624PyrazinamideTablet 750mg1 Tablet6.4325PhenobarbitoneTablet 30mg1 Tablet1.1726AmiodaroneTablet 200mg1 Tablet10.2727EthambutolTablet 400mg1 Tablet2.3328FluconazoleTablet 100mg1 Tablet6.8029AzathioprineTablet 50mg1 Tablet10.0430AllopurinolTablet 100mg1 Tablet1.6931PropranololTablet 10mg1 Tablet1.1732HydroxychloroquineTablet 200mg1 Tablet5.6733CarbimazoleTablet 10mg1 Tablet3.8034CefiximeTablet 200mg1 Tablet8.7235ImatinibTablet 100mg1 Tablet62.2136TamoxifenTablet 20mg1 Tablet2.6337TamoxifenTablet 10mg1 Tablet1.9738L-AsparaginasePowder for Injection 5000 KU1 Vial922.94  39  L-AsparaginasePowder for Injection 10000KU  1 Vial  1523.0340DacarbazinePowder for Injection 200mg1 Vial340.4641MefloquineTablet 250 mg1 Tablet46.5242ThalidomideCapsule 50 mg1 Capsule27.7943ThalidomideCapsule 100mg1 Capsule55.3144ClonazepamTablet 0.25mg1 Tablet1.80

45ClonazepamTablet 0.5mg1 Tablet3.0846ClonazepamTablet 1mg1 Tablet4.2547ClozapineTablet 25mg1 Tablet2.4848ClozapineTablet 50mg1 Tablet4.6349ClozapineTablet 100 mg1 Tablet7.5450MetronidazoleTablet 200mg1 Tablet0.7351MetronidazoleTablet 400mg1 Tablet1.3652HydroxyureaCapsule 500mg1 Capsule10.8153IbuprofenTablet 200mg1 Tablet0.6354AcetazolamideTablet 250mg1 Tablet3.6255CiprofloxacinTablet 250mg1 tablet1.9656SalbutamolTablet 4 mg1 Tablet0.1957SalbutamolTablet 2 mg1 Tablet0.1658MetoclopramideTablet 10mg1 Tablet1.20  59Amoxicillin (A) +Clavulanic acid (B)Tablet 500 mg (A) + 125 mg (B)  1 Tablet  16.3260DocetaxelPowder for Injection 20mg1 Vial2558.1461ClopidogrelTablet 75mg1 Tablet5.9462HydrocortisonePowder for Injection 100mg1 Vial39.9563GemcitabinePowder for Injection 1000mg1 Vial4987.6564MethotrexateTablet 10mg1 tablet11.8565MethotrexateTablet 2.5mg1 tablet4.7466DiltiazemTablet 60mg1 Tablet4.8767AmiodaroneTablet 100mg1 Tablet5.4868Dom1idoneTablet 10mg1 Tablet2.0669QuinineTablet 300 mg1 Tablet5.0470EnalaprilTablet 5mg1 Tablet3.3071EnalaprilTablet 2.5mg1 Tablet1.95

72AcyclovirTablet 400mg1 Tablet12.1873AcyclovirTablet 200mg1 Tablet6.7974RifampicinCapsule 450mg1 Capsule5.06  75Zidovudine (A) +Lamivudine(B)  Tablet 300mg(A)+150mg(B)  1 Tablet  18.8176PrimaquineTablet 7.5mg1 Tablet2.1277NitrofurantoinTablet 100 mg1 Tablet7.2378CiprofloxacinTablet 500mg1 tablet3.7979OndansetronTablet 8 mg1 Tablet7.9480GriseofulvinTablet 250mg1 Tablet1.5881EscitalopramTablet 5mg1 Tablet4.4882EscitalopramTablet 10mg1 Tablet8.0383EscitalopramTablet 20mg1 Tablet12.8184GemcitabinePowder for Injection 200 mg1 Vial1159.2185CeftazidimePowder for Injection 1000mg1 Vial202.4786DiclofenacTablet 50mg1 Tablet1.8387CarbamazepineTablet 200mg1 Tablet1.40  88Amoxicillin (A) + Clavulanic acid (B)Powder for Injection 1 g (A) +200mg (B)  1 Vial  125.4489BisacodylTablet 5mg1 Tablet1.0490PantoprazoleInjection 40mg1 Vial45.00  91Ethinylestradiol (A)+ Levonorgestrel (B)Tablet 0.03mg(A) + Tablet 0.15mg(B)  1 Tablet  2.8392NorethisteroneTablet 5mg1 Tablet4.8193CarbimazoleTablet 5mg1 Tablet1.95

Click for more articles on NPPA

Note:(a) All manufacturers of scheduled formulation, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.

(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.

(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above-said table.

Click for more articles on DPCO 2013

(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO 2013.

The manufacturer shall issue a price list in Form–V from the date of the Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner to be easily accessible to any person wishing to consult the same.

(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule II of the DPCO, 2013.

(g) The manufacturers of above said scheduled formulations shall furnish quarterly returns to the NPPA, in respect of the production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS.

Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.

(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the DPCO 2013 read with Essential Commodities Act, 1955.

(i) Consequent to the issue of the ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above-said date of notification, stand(s) superseded.

Latest on National Pharmaceutical Pricing Authority (NPPA)

Latest notifications – DPCO / NPPA

NPPA updated price lists: Download

Latest Notifications: EC Act (Essential Commodities Act)

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

National List of Essential Medicines (NLEM)

NPPA fixes Retail Price of 4 scheduled formulations: January 2023

NPPA fixes retail price of 36 formulations: January 2023

NPPA fixes Retail Price of 10 formulations: December 2022

NPPA fixes Retail Price of 12 scheduled formulations: December 2022

NPPA revises Retail Price of 107 scheduled formulations: December 2022

NPPA fixes Retail Price of one formulation: November 2022

USFDA issues warning letter to Sun Pharma for its Gujarat plant

Tramadol: 3 Pharmaceutical Companies under scanner

NMC allows foreign medical graduates to finish internship in India

NABL suspends accreditation of 80 laboratories

NPPA fixes Retail Price of 4 scheduled formulations: January 2023

Medical Oxygen plants to be put on digital map

JIPMER: Nursing Officer 2022 result declared, Download

List of approved FDCs (Fixed Dose Combinations) Updated

List of approved New Drugs Updated

Latest Notifications regarding Pharmaceutical
https://thehealthmaster.com/2023/01/14/nppa-revised-retail-price-of-93-scheduled-formulations-january-2023/